|
HPS5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.43989997492389E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67659999994463E-07 |
| Normal-vs-Stage2 |
3.1562000000207E-06 |
| Normal-vs-Stage3 |
3.1713000003819E-07 |
| Normal-vs-Stage4 |
4.70629979432147E-10 |
| Stage1-vs-Stage2 |
5.102000E-01 |
| Stage1-vs-Stage3 |
2.700600E-01 |
| Stage1-vs-Stage4 |
8.557600E-03 |
| Stage2-vs-Stage3 |
8.756400E-01 |
| Stage2-vs-Stage4 |
1.179620E-01 |
| Stage3-vs-Stage4 |
1.350630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.58790000037712E-08 |
| Normal-vs-AfricanAmerican |
8.537900E-03 |
| Normal-vs-Asian |
2.17609999999535E-05 |
| Caucasian-vs-AfricanAmerican |
3.120400E-01 |
| Caucasian-vs-Asian |
9.940400E-01 |
| AfricanAmerican-vs-Asian |
4.063600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05559999963312E-07 |
| Normal-vs-Female |
1.25939999540137E-08 |
| Male-vs-Female |
6.210800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.51730999999877E-05 |
| Normal-vs-Age(41-60Yrs) |
2.81040002381161E-09 |
| Normal-vs-Age(61-80Yrs) |
4.63689999730121E-08 |
| Normal-vs-Age(81-100Yrs) |
9.735700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.020970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.214750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.880800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.137600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.149400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.543200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.627600E-01 |
| Classical-VS-Follicular |
6.984100E-03 |
| Classical-VS-Other |
1.416370E-01 |
| Classical-VS-Normal |
8.38289999971487E-07 |
| Tall-VS-Follicular |
3.682000E-01 |
| Tall-VS-Other |
3.180200E-01 |
| Tall-VS-Normal |
1.245010E-04 |
| Follicular-VS-Other |
5.820000E-01 |
| Follicular-VS-Normal |
3.10619996390926E-09 |
| Other-VS-Normal |
6.044000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.9492998588363E-10 |
| Normal-vs-N1 |
1.80729999965656E-07 |
| N0-vs-N1 |
5.808600E-01 |
|
|
